Piramal Healthcare gains on investing 2 million pounds in Scottish plant

19 Nov 2015 Evaluate

Piramal Enterprises is currently trading at Rs. 999.05, up by 3.95 points or 0.40% from its previous closing of Rs. 995.10 on the BSE.

The scrip opened at Rs. 999.00 and has touched a high and low of Rs. 1004.95 and Rs. 989.00 respectively. So far 2198 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1043.00 on 20-May-2015 and a 52 week low of Rs. 750.95 on 17-Dec-2014.

Last one week high and low of the scrip stood at Rs. 1012.00 and Rs. 956.00 respectively. The current market cap of the company is Rs. 17239.92 crore.

The promoters holding in the company stood at 52.82%, while Institutions and Non-Institutions held 30.91% and 16.27% respectively.

In a bid to expand its manufacturing plant in Scotland, Piramal Healthcare has invested two million pounds. The company is aiming to expand this facility in the next 5 years to maintain its position as a global leader in the production of antibody drug conjugates.

The plant manufactures anti-cancer drugs (antibody drug conjugates) for export. The investment of two million pounds into Scotland will yield additional revenue of 3-5 million pounds over five years to Piramal Healthcare’s revenue.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Healthcare, Healthcare Information Management and Financial Services. Its consolidated revenues were over $830 million in FY2015, with approx. 70% of revenues from outside India.

 

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers
Company Name CMP
Bajaj Finance 997.60
Shriram Finance 955.35
Aditya Birla Capital 346.80
Chola Invest & Fin. 1698.35
Tata Capital 337.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×